Results 201 to 210 of about 648,282 (342)

Placebo response in RCT for antidepressant may not always be the 'villain' to fight: are KOR antagonists possibly affecting the intrinsic placebo response? [PDF]

Neuropsychopharmacology
Merlo Pich E.
europepmc   +1 more source

Correction to: Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis. [PDF]

Schizophr Bull, 2023
europepmc   +1 more source

The role of placebo response in the efficacy outcome assessment in viloxazine extended-release pivotal trials in paediatric subjects with attention-deficit/hyperactivity disorder. [PDF]

Br J Clin Pharmacol, 2022
Nasser A, Gomeni R, Wang Z, Hull JT, Busse GD, Melyan Z, Fava M, O'Neal W, Rubin J.   +8 more
europepmc   +1 more source

Dekonstruktion af Placebo Effekten og fundet af Betydningsrespons: (oversættelse af originalartikel af Daniel Moerman & Wayne Jonas: Deconstructing the Placebo Effect and Finding the Meaning Response)

, 2015
Ann Ostenfeld-Rosenthal, Helle Johannessen   +1 more
openalex   +1 more source

Response to Letter Regarding Article, “Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial” [PDF]

, 2010
Douglas L. Packer, Robert P. Frantz, Jordan M. Prutkin, Jeanne E. Poole, Anne S. Hellkamp, Freda Wood, Steve E. McNulty, Joseph G. Rogers, Daniel B. Mark, Kerry L. Lee, L. Brent Mitchell, Robert Bernstein, John Boehmer, Mark D. Carlson, Jill Anderson, Gust H. Bardy, George Johnson, Mary Norine Walsh   +17 more
openalex   +1 more source

Measuring the Impact: MRI Response of Sacroiliac Joints to TNF Inhibitors in Youth with Axial Disease

Arthritis &Rheumatology, Accepted Article.
Objective To evaluate the timeline for resolution of sacroiliac joint (SIJ) inflammation, changes in structural lesions, and their correlation with patient‐reported outcomes in youth with axial juvenile spondyloarthritis (axJSpA) initiating TNF inhibitor (TNFi).
Timothy G. Brandon, Rui Xiao, Daniel J. Lovell, Edward Oberle, Matthew L. Stoll, Nancy A. Chauvin, Michael L. Francavilla, Walter P. Maksymowych, Pamela F. Weiss   +8 more
wiley   +1 more source

Decoding the impact of the placebo response in clinical trials for chronic cough. [PDF]

ERJ Open Res
Zhang M, Zhang B, Morice AH.
europepmc   +1 more source

What can be done to control the placebo response in clinical trials? A narrative review. [PDF]

Contemp Clin Trials, 2021
Evans K, Colloca L, Pecina M, Katz N.
europepmc   +1 more source

Effect of synbiotic in constipated adult women – A randomized, double-blind, placebo-controlled study of clinical response [PDF]

, 2012
Dan Linetzky Waitzberg, L. Logullo, Amanda F. Bittencourt, Raquel Susana Torrinhas, Glaucia M. Shiroma, Natalia P. Paulino, Maria L. Teixeira-da-Silva   +6 more
openalex   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source